Angiogenesis in non-small cell lung cancer: imaging with perfusion computed tomography.

Manipulation of tumor vasculature has emerged as a promising therapeutic strategy in advanced non-small cell lung cancer (NSCLC). Bevacizumab has been licensed for first-line therapy in combination with standard chemotherapy in advanced NSCLC, whereas inhibitors of platelet-derived growth factor receptors and other tyrosine kinases are currently in clinical trials for the treatment of advanced NSCLC. Perfusion computed tomography is a promising biomarker in NSCLC. As a measure of tumor perfusion and angiogenesis, perfusion computed tomography may provide invaluable pharmacodynamic information in early-phase clinical trials, monitor the vascular effects of antiangiogenic or vascular-targeting drug treatment, and provide prognostic and predictive information. Current volumetric techniques, affording a coverage of up to 28 cm, permit clinically relevant, high-quality, whole tumor evaluation.

[1]  Steve Halligan,et al.  Colorectal tumor vascularity: quantitative assessment with multidetector CT--do tumor perfusion measurements reflect angiogenesis? , 2008, Radiology.

[2]  S. Goldberg,et al.  CT perfusion for determination of pharmacologically mediated blood flow changes in an animal tumor model. , 2007, Radiology.

[3]  C. Mountain,et al.  Staging classification of lung cancer. A critical evaluation. , 2002, Clinics in chest medicine.

[4]  F. Blackhall,et al.  Gefitinib for the treatment of non-small-cell lung cancer , 2010, Expert opinion on pharmacotherapy.

[5]  F. Shepherd,et al.  Targeting Angiogenesis in the Treatment of Lung Cancer , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[6]  K. Miles,et al.  Warburg revisited: imaging tumour blood flow and metabolism , 2008, Cancer imaging : the official publication of the International Cancer Imaging Society.

[7]  K. Uematsu,et al.  Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer. , 2006, Lung cancer.

[8]  H. Fichte,et al.  Quantitative assessment of lung cancer perfusion using MDCT: does measurement reproducibility improve with greater tumor volume coverage? , 2006, AJR. American journal of roentgenology.

[9]  D. McDonald,et al.  Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors. , 2003, The American journal of pathology.

[10]  A. Harris,et al.  Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer. , 2000, Cancer research.

[11]  F. D'armiento,et al.  Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model. , 2004, Molecular cancer therapeutics.

[12]  A. Harris,et al.  Serum vascular endothelial growth factor load and interleukin-6 in cancer patients , 2000, British Journal of Cancer.

[13]  J. Folkman,et al.  The role of angiogenesis in tumor growth. , 1992, Seminars in cancer biology.

[14]  Holger Gerhardt,et al.  Endothelial-pericyte interactions in angiogenesis , 2003, Cell and Tissue Research.

[15]  J. Verdebout,et al.  The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis , 2002, British Journal of Cancer.

[16]  R. Herbst,et al.  Tumor Blood Flow Measured by Perfusion Computed Tomography and 15O-Labeled Water Positron Emission Tomography: A Comparison Study , 2009, Journal of computer assisted tomography.

[17]  M. Dewhirst,et al.  Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. , 1996, Cancer research.

[18]  L. Tanoue.  Cancer Statistics, 2009 , 2010 .

[19]  D. Hanahan,et al.  Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.

[20]  M. Jinzaki,et al.  Double-Phase Helical CT of Small Renal Parenchymal Neoplasms: Correlation with Pathologic Findings and Tumor Angiogenesis , 2000, Journal of computer assisted tomography.

[21]  Vicky Goh,et al.  Effect of nitric-oxide synthesis on tumour blood volume and vascular activity: a phase I study. , 2007, The Lancet. Oncology.

[22]  Edward F. Jackson,et al.  A phase I surrogate endpoint study of SU6668 in patients with solid tumors , 2004, Investigational New Drugs.

[23]  A. Harris,et al.  Microvessel density as a prognostic factor in non-small-cell lung carcinoma: a meta-analysis of individual patient data. , 2007, The Lancet. Oncology.

[24]  R. Gray,et al.  Outcomes for elderly, advanced-stage non small-cell lung cancer patients treated with bevacizumab in combination with carboplatin and paclitaxel: analysis of Eastern Cooperative Oncology Group Trial 4599. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  I. Wistuba,et al.  Mismatch repair gene expression and genetic instability in testicular germ cell tumor , 2004, Cancer biology & therapy.

[26]  Vicky Goh,et al.  Acute tumor vascular effects following fractionated radiotherapy in human lung cancer: In vivo whole tumor assessment using volumetric perfusion computed tomography. , 2007, International journal of radiation oncology, biology, physics.

[27]  K. Yamashita,et al.  Intratumoral Necrosis of Lung Carcinoma: A Potential Diagnostic Pitfall in Incremental Dynamic Computed Tomography Analysis of Solitary Pulmonary Nodules? , 1997, Journal of thoracic imaging.

[28]  Yu Wang,et al.  Dynamic CT Evaluation of Tumor Vascularity in Renal Cell Carcinoma. , 2006, AJR. American journal of roentgenology.

[29]  G. Semenza,et al.  Meeting report: exploiting the tumor microenvironment for therapeutics. , 2006, Cancer research.

[30]  Chryso Kanthou,et al.  Disrupting tumour blood vessels , 2005, Nature Reviews Cancer.

[31]  A. Schor,et al.  Prognostic value of vascularity and vascular endothelial growth factor expression in non-small cell lung cancer , 2001, Journal of clinical pathology.

[32]  R K Jain,et al.  Openings between defective endothelial cells explain tumor vessel leakiness. , 2000, The American journal of pathology.

[33]  Fabian Kiessling,et al.  Perfusion CT in patients with advanced bronchial carcinomas: a novel chance for characterization and treatment monitoring? , 2004, European Radiology.

[34]  F. Lee,et al.  Effects of combretastatin A4 phosphate on endothelial cell morphology in vitro and relationship to tumour vascular targeting activity in vivo. , 2001, Anticancer research.

[35]  K. O'Byrne,et al.  Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer , 2000, British Journal of Cancer.

[36]  Zhuang-Wei Xiao,et al.  Peripheral pulmonary nodules: Relationship between multi-slice spiral CT perfusion imaging and tumor angiogenesis and VEGF expression , 2008, BMC Cancer.

[37]  S. Hill,et al.  Temporal heterogeneity in microregional erythrocyte flux in experimental solid tumours. , 1995, British Journal of Cancer.

[38]  Robert Gray,et al.  Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. , 2006, The New England journal of medicine.

[39]  Chryso Kanthou,et al.  Radiation effects on the cytoskeleton of endothelial cells and endothelial monolayer permeability. , 2007, International journal of radiation oncology, biology, physics.

[40]  H. Wada,et al.  Expression of angiopoietins and its clinical significance in non-small cell lung cancer. , 2002, Cancer research.

[41]  C. Yi,et al.  Solitary pulmonary nodules: dynamic enhanced multi-detector row CT study and comparison with vascular endothelial growth factor and microvessel density. , 2004, Radiology.

[42]  T. Vogl,et al.  Functional CT of squamous cell carcinoma in the head and neck: repeatability of tumor and muscle quantitative measurements, inter- and intra-observer agreement , 2008, European Radiology.

[43]  Rakesh K. Jain,et al.  Transport of molecules across tumor vasculature , 2004, Cancer and Metastasis Reviews.

[44]  H L Fung,et al.  Reversed-phase high-performance liquid chromatography method for the analysis of nitro-arginine in rat plasma and urine. , 1996, Journal of chromatography. B, Biomedical applications.

[45]  M. Socinski,et al.  Multicenter, phase II trial of sunitinib in previously treated, advanced non-small-cell lung cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[46]  H. Augustin,et al.  Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. , 2000, Cancer research.

[47]  J. Silverman,et al.  Vascular Endothelial Growth Factor Expression in Stage I Non-Small Cell Lung Cancer Correlates With Neoangiogenesis and a Poor Prognosis , 2001, Annals of Surgical Oncology.

[48]  Vicky Goh,et al.  Tumor antivascular effects of radiotherapy combined with combretastatin a4 phosphate in human non-small-cell lung cancer. , 2007, International journal of radiation oncology, biology, physics.

[49]  Ernst Klotz,et al.  Perfusion CT: noninvasive surrogate marker for stratification of pancreatic cancer response to concurrent chemo- and radiation therapy. , 2009, Radiology.

[50]  Ricky T. Tong,et al.  Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer , 2004, Nature Medicine.

[51]  R K Jain,et al.  Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy. , 1990, Cancer research.

[52]  V. Goh,et al.  Can perfusion CT assessment of primary colorectal adenocarcinoma blood flow at staging predict for subsequent metastatic disease? A pilot study , 2008, European Radiology.

[53]  Y. Maehara,et al.  Platelet-derived growth factor-AA is an essential and autocrine regulator of vascular endothelial growth factor expression in non-small cell lung carcinomas. , 2005, Cancer research.

[54]  G. Tozer,et al.  Inhibition of nitric oxide synthase induces a selective reduction in tumor blood flow that is reversible with L-arginine. , 1997, Cancer research.

[55]  C. Angeletti,et al.  Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[56]  Massimo Bellomi,et al.  CT perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma: initial experience. , 2007, Radiology.

[57]  D. Sahani,et al.  Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: initial observations. , 2005, Radiology.

[58]  G. Tozer.  Measuring tumour vascular response to antivascular and antiangiogenic drugs. , 2003, The British journal of radiology.

[59]  Jia-Yu Sun,et al.  Peripheral lung carcinoma: correlation of angiogenesis and first-pass perfusion parameters of 64-detector row CT. , 2008, Lung cancer.

[60]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[61]  Ernst Klotz,et al.  Lung cancer perfusion at multi-detector row CT: reproducibility of whole tumor quantitative measurements. , 2006, Radiology.

[62]  V. Goh,et al.  Quantitative assessment of tissue perfusion using MDCT: comparison of colorectal cancer and skeletal muscle measurement reproducibility. , 2006, AJR. American journal of roentgenology.

[63]  F R Verdun,et al.  Using 80 kVp versus 120 kVp in perfusion CT measurement of regional cerebral blood flow. , 2000, AJNR. American journal of neuroradiology.

[64]  K. Miles,et al.  Blood flow–metabolic relationships are dependent on tumour size in non-small cell lung cancer: a study using quantitative contrast-enhanced computer tomography and positron emission tomography , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[65]  N. Müller,et al.  Lung nodule enhancement at CT: multicenter study. , 2000, Radiology.

[66]  R. Haba,et al.  The clinical significance of lymphangiogenesis and angiogenesis in non-small cell lung cancer patients. , 2008, European journal of cancer.

[67]  M. Liao,et al.  Vascular endothelial growth factor and other biological predictors related to the postoperative survival rate on non-small cell lung cancer. , 2001, Lung cancer.

[68]  M. Koukourakis,et al.  Early Antivascular Effects of Bevacizumab Anti-VEGF Monoclonal Antibody on Colorectal Carcinomas Assessed With Functional CT Imaging , 2007, American journal of clinical oncology.

[69]  Y.P. Deng,et al.  Whole tumour perfusion of peripheral lung carcinoma: evaluation with first-pass CT perfusion imaging at 64-detector row CT. , 2008, Clinical radiology.

[70]  G. Thurston.  Role of Angiopoietins and Tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis , 2003, Cell and Tissue Research.

[71]  Masahiko Kusumoto,et al.  Contrast‐enhanced dynamic computed tomography for the evaluation of tumor angiogenesis in patients with lung carcinoma , 2002, Cancer.

[72]  J. Folkman,et al.  Clinical translation of angiogenesis inhibitors , 2002, Nature Reviews Cancer.

[73]  M Kono,et al.  Solitary pulmonary nodules: evaluation of blood flow patterns with dynamic CT. , 1997, Radiology.

[74]  Johan Vansteenkiste,et al.  Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[75]  Martijn R. Meijerink,et al.  The use of perfusion CT for the evaluation of therapy combining AZD2171 with gefitinib in cancer patients , 2007, European Radiology.

[76]  Andreas Friedl,et al.  Phase I pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[77]  S. Sleijfer,et al.  The use of bevacizumab in colorectal, lung, breast, renal and ovarian cancer: where does it fit? , 2008, European journal of cancer.

[78]  H. Dvorak,et al.  Structure of solid tumors and their vasculature: implications for therapy with monoclonal antibodies. , 1991, Cancer cells.

[79]  L. Schwartz,et al.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.

[80]  Ruth C Carlos,et al.  Solitary pulmonary nodules: meta-analytic comparison of cross-sectional imaging modalities for diagnosis of malignancy. , 2008, Radiology.

[81]  Kazuo Miyasaka,et al.  Lung Tumors Evaluated With FDG-PET and Dynamic CT: The Relationship Between Vascular Density and Glucose Metabolism , 2002, Journal of computer assisted tomography.

[82]  Massimo Bellomi,et al.  Perfusion Computed Tomography for Monitoring Induction Chemotherapy in Patients With Squamous Cell Carcinoma of the Upper Aerodigestive Tract: Correlation Between Changes in Tumor Perfusion and Tumor Volume , 2009, Journal of computer assisted tomography.

[83]  B. Skov,et al.  Vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 expression in non-small cell lung cancer patients: relation to prognosis. , 2009 .

[84]  J R Griffiths,et al.  Clinical studies. , 2005, Advances in pharmacology.

[85]  L. Liotta,et al.  Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[86]  K. Miles,et al.  Perfusion CT for the assessment of tumour vascularity: which protocol? , 2003, The British journal of radiology.

[87]  Z. Rumboldt,et al.  Outcome prediction after surgery and chemoradiation of squamous cell carcinoma in the oral cavity, oropharynx, and hypopharynx: use of baseline perfusion CT microcirculatory parameters vs. tumor volume. , 2009, International journal of radiation oncology, biology, physics.

[88]  T. Purdie,et al.  Functional CT imaging of angiogenesis in rabbit VX2 soft-tissue tumour. , 2001, Physics in medicine and biology.

[89]  Jin-Hyuk Choi,et al.  Serum angiopoietin-1 as a prognostic marker in resected early stage lung cancer. , 2009, Lung cancer.